J Korean Med Sci.  2015 Dec;30(12):1920-1921. 10.3346/jkms.2015.30.12.1920.

Thyroid Cancer: We Need a Carcinogen-specific Genome Study

Affiliations
  • 1Department of Preventive Medicine, Jeju National University School of Medicine, Jeju, Korea. jmbae@jejunu.ac.kr

Abstract

No abstract available.


MeSH Terms

Adult
Carcinogens/toxicity
Environmental Exposure
Genome, Human/radiation effects
Humans
Neoplasms, Radiation-Induced/epidemiology/etiology/*genetics
*Nuclear Power Plants
Republic of Korea/epidemiology
Thyroid Neoplasms/epidemiology/etiology/*genetics
Carcinogens

Reference

1. Jung KW, Won YJ, Kong HJ, Oh CM, Cho H, Lee DH, Lee KH. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat. 2015; 47:127–141.
2. Oh CM, Jung KW, Won YJ, Shin A, Kong HJ, Lee JS. Age-period-cohort analysis of thyroid cancer incidence in Korea. Cancer Res Treat. 2015; 47:362–369.
3. Ahn HS, Kim HJ, Welch HG. Korea's thyroid-cancer "epidemic"--screening and overdiagnosis. N Engl J Med. 2014; 371:1765–1767.
4. Kim CS. Thyroid cancer and radiation. J Korean Thyroid Assoc. 2015; 8:1–7.
5. Ahn YO, Li ZM. KREEC Study Group. Cancer risk in adult residents near nuclear power plants in Korea - a cohort study of 1992-2010. J Korean Med Sci. 2012; 27:999–1008.
6. Kim JM, Kim MH, Ju YS, Hwang SS, Ha M, Paek D. Re: cancer risk in adult residents near nuclear power plants in Korea: a cohort study of 1992-2010. J Korean Med Sci. 2014; 29:1436–1437.
7. Kim JM, Kim MH, Ju YS, Hwang SS, Ha M, Paek D. Rebuttal to authors' reply, re: cancer risk in adult residents near nuclear power plants in Korea: a cohort study of 1992-2010. J Korean Med Sci. 2015; 30:115–116.
8. Lee WJ. Cancer risk among population near nuclear power plants in Korea. J Korean Med Sci. 2015; 30:666–667.
9. Bae JM. A case report about doubting a misconduction of publication by a third party based on the confusing ownership of databases. J Med Life Sci. 2014; 11:77–81.
10. Reiners C. Radioactivity and thyroid cancer. Hormones (Athens). 2009; 8:185–191.
11. Moysich KB, Menezes RJ, Michalek AM. Chernobyl-related ionising radiation exposure and cancer risk: an epidemiological review. Lancet Oncol. 2002; 3:269–279.
12. Davis S, Kopecky KJ, Hamilton TE, Onstad L. Hanford Thyroid Disease Study Team. Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the hanford nuclear site. JAMA. 2004; 292:2600–2613.
13. Bollaerts K, Fierens S, Van Bladel L, Simons K, Sonck M, Poffijn A, Geraets D, Gosselin P, Van Oyen H, Francart J, et al. Thyroid cancer incidence in the vicinity of nuclear sites in Belgium, 2000-2008. Thyroid. 2014; 24:906–917.
14. Dinets A, Hulchiy M, Sofiadis A, Ghaderi M, Höög A, Larsson C, Zedenius J. Clinical, genetic, and immunohistochemical characterization of 70 Ukrainian adult cases with post-Chornobyl papillary thyroid carcinoma. Eur J Endocrinol. 2012; 166:1049–1060.
15. Leeman-Neill RJ, Brenner AV, Little MP, Bogdanova TI, Hatch M, Zurnadzy LY, Mabuchi K, Tronko MD, Nikiforov YE. RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics. Cancer. 2013; 119:1792–1799.
16. Tronko M, Bogdanova T, Voskoboynyk L, Zurnadzhy L, Shpak V, Gulak L. Radiation induced thyroid cancer: fundamental and applied aspects. Exp Oncol. 2010; 32:200–204.
17. HuGE Navigator. Phenopedia. accessed on 18 July 2015. Available at http://hugenavigator.net/HuGENavigator/startPagePhenoPedia.do.
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr